Works by Terkeltaub, Robert
Results: 102
Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulators.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-74154-5
- By:
- Publication type:
- Article
Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease : A Population-Based Cohort Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0212235
- By:
- Publication type:
- Article
Prediagnostic Amino Acid Metabolites and Risk of Gout, Accounting for Serum Urate: Prospective Cohort Study and Mendelian Randomization.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 12, p. 1666, doi. 10.1002/acr.25420
- By:
- Publication type:
- Article
Superiority of Low‐Dose Benzbromarone Add‐On to Low‐Dose Febuxostat Compared With Febuxostat Monotherapy in Gout With Combined‐Type Hyperuricemia.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 5, p. 703, doi. 10.1002/acr.25283
- By:
- Publication type:
- Article
COVID‐19 Vaccination and Gout Flare Risk in Patients With Infrequent or Frequent Flares: A Prospective Cohort Study.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 1, p. 131, doi. 10.1002/acr.25215
- By:
- Publication type:
- Article
Proton‐Pump Inhibitors and Risk of Calcium Pyrophosphate Deposition in a Population‐Based Study.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 12, p. 2059, doi. 10.1002/acr.24876
- By:
- Publication type:
- Article
Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.
- Published in:
- Arthritis Care & Research, 2012, v. 64, n. 10, p. 1462, doi. 10.1002/acr.21690
- By:
- Publication type:
- Article
Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. 1, doi. 10.1186/s13075-020-2129-y
- By:
- Publication type:
- Article
Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. 1, doi. 10.1186/s13075-018-1788-4
- By:
- Publication type:
- Article
Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1699-4
- By:
- Publication type:
- Article
Interleukin-8 and its receptor CXCR2 in atherosclerosis.
- Published in:
- Immunologic Research, 2000, v. 21, n. 2/3, p. 129, doi. 10.1385/IR:21:2-3:129
- By:
- Publication type:
- Article
Erratum: the mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy (GACI).
- Published in:
- Human Mutation, 2005, v. 26, n. 5, p. 495, doi. 10.1002/humu.9380
- By:
- Publication type:
- Article
The mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy (GACI).
- Published in:
- Human Mutation, 2005, v. 25, n. 1, p. 98, doi. 10.1002/humu.9297
- By:
- Publication type:
- Article
Gout in 2006.
- Published in:
- Bulletin of the NYU Hospital for Joint Diseases, 2006, v. 64, n. 1/2, p. 82
- By:
- Publication type:
- Article
Npp1 promotes atherosclerosis in ApoE knockout mice.
- Published in:
- Journal of Cellular & Molecular Medicine, 2011, v. 15, n. 11, p. 2273, doi. 10.1111/j.1582-4934.2011.01327.x
- By:
- Publication type:
- Article
Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Feasibility of conducting a randomized, placebo-controlled study assessing whether omega-3 fatty acids prevent gout flares when starting urate-lowering treatment.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 3, p. 1, doi. 10.1093/rap/rkac086
- By:
- Publication type:
- Article
A fly GWAS for purine metabolites identifies human FAM214 homolog medusa, which acts in a conserved manner to enhance hyperuricemia-driven pathologies by modulating purine metabolism and the inflammatory response.
- Published in:
- GeroScience, 2022, v. 44, n. 4, p. 2195, doi. 10.1007/s11357-022-00557-9
- By:
- Publication type:
- Article
Novel Genetic Loci in Early‐Onset Gout Derived From Whole‐Genome Sequencing of an Adolescent Gout Cohort.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 1, p. 107, doi. 10.1002/art.42969
- By:
- Publication type:
- Article
Hyperuricemia Subtypes Classified According to Renal Uric Acid Handling Manifesting Distinct Phenotypic and Genetic Profiles in People With Gout.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 7, p. 1130, doi. 10.1002/art.42838
- By:
- Publication type:
- Article
Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 12, p. 2252, doi. 10.1002/art.42635
- By:
- Publication type:
- Article
Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population‐Based, Prospective Study and Mendelian Randomization Analysis.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 9, p. 1648, doi. 10.1002/art.42523
- By:
- Publication type:
- Article
Serum Urate–Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Trial.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 7, p. 1275, doi. 10.1002/art.42447
- By:
- Publication type:
- Article
Superiority of Low‐Dose Benzbromarone to Low‐Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 12, p. 2015, doi. 10.1002/art.42266
- By:
- Publication type:
- Article
Association Between Gut Microbiota and Elevated Serum Urate in Two Independent Cohorts.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 4, p. 682, doi. 10.1002/art.42009
- By:
- Publication type:
- Article
Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 9, p. 1738, doi. 10.1002/art.41733
- By:
- Publication type:
- Article
A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 8, p. 1533, doi. 10.1002/art.41699
- By:
- Publication type:
- Article
Reassessing the Cardiovascular Safety of Febuxostat: Implications of the Febuxostat versus Allopurinol Streamlined Trial.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 5, p. 721, doi. 10.1002/art.41638
- By:
- Publication type:
- Article
Differential DNA Methylation of Networked Signaling, Transcriptional, Innate and Adaptive Immunity, and Osteoclastogenesis Genes and Pathways in Gout.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 5, p. 802, doi. 10.1002/art.41173
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Effect of Dietary and Supplemental Omega‐3 Polyunsaturated Fatty Acids on Risk of Recurrent Gout Flares.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 9, p. 1580, doi. 10.1002/art.40896
- By:
- Publication type:
- Article
Reply.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 3, p. 481, doi. 10.1002/art.40742
- By:
- Publication type:
- Article
New Perspectives in Rheumatology: Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 11, p. 1702, doi. 10.1002/art.40583
- By:
- Publication type:
- Article
Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 8, p. 1182, doi. 10.1002/art.40517
- By:
- Publication type:
- Article
Impaired Proteasomal Function in Human Osteoarthritic Chondrocytes Can Contribute to Decreased Levels of SOX9 and Aggrecan.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 7, p. 1030, doi. 10.1002/art.40456
- By:
- Publication type:
- Article
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 9, p. 1903, doi. 10.1002/art.40159
- By:
- Publication type:
- Article
Review: Gout: A Roadmap to Approaches for Improving Global Outcomes.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 1, p. 22, doi. 10.1002/art.39799
- By:
- Publication type:
- Article
Mitochondrial Biogenesis Is Impaired in Osteoarthritis Chondrocytes but Reversible via Peroxisome Proliferator-Activated Receptor γ Coactivator 1α.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Mitochondrial Biogenesis Is Impaired in Osteoarthritis Chondrocytes but Reversible via Peroxisome Proliferator-Activated Receptor γ Coactivator 1α.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 8, p. 2141, doi. 10.1002/art.39182
- By:
- Publication type:
- Article
Editorial: Can GPR43 Sensing of Short-Chain Fatty Acids Unchain Inflammasome-Driven Arthritis?
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 6, p. 1419, doi. 10.1002/art.39102
- By:
- Publication type:
- Article
Peroxisome Proliferator-Activated Receptor γ Coactivator 1α and FoxO3A Mediate Chondroprotection by AMP-Activated Protein Kinase.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Peroxisome Proliferator-Activated Receptor γ Coactivator 1α and FoxO3A Mediate Chondroprotection by AMP-Activated Protein Kinase.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, n. 11, p. 3073, doi. 10.1002/art.38791
- By:
- Publication type:
- Article
The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.
- Published in:
- Rheumatology, 2024, v. 63, n. 4, p. 1058, doi. 10.1093/rheumatology/kead333
- By:
- Publication type:
- Article
Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study.
- Published in:
- Rheumatology, 2023, v. 62, n. 7, p. 2435, doi. 10.1093/rheumatology/keac656
- By:
- Publication type:
- Article
Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout.
- Published in:
- Rheumatology, 2019, v. 58, n. 1, p. 61, doi. 10.1093/rheumatology/key245
- By:
- Publication type:
- Article
PPARGC1B: insight into the expression of the gouty inflammation phenotype.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Predictors of Inadequate Serum Urate Response to Low-Dose Febuxostat in Male Patients with Gout.
- Published in:
- Journal of Inflammation Research, 2024, v. 17, p. 2657, doi. 10.2147/JIR.S458250
- By:
- Publication type:
- Article
Linked decreases in liver kinase B1 and AMP-activated protein kinase activity modulate matrix catabolic responses to biomechanical injury in chondrocytes.
- Published in:
- Arthritis Research & Therapy, 2013, v. 15, n. 4, p. R77, doi. 10.1186/ar4254
- By:
- Publication type:
- Article